Navigation Links
Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007
Date:2/4/2008

18

Electrophysiology 13 11 2

Neurovascular 26 15 11

Cardiac Surgery 62 62 -

Cardiac Rhythm Management 753 702 51

CARDIOVASCULAR 320 178 142

Oncology 12 7 5

Endoscopy 89 65 24

Urology 32 28 4

ENDOSURGERY 133 100 33

NEUROMODULATION 83 78 5

WORLDWIDE $536 $356 $180

An explanation of the ways in which Boston Scientific management uses

these non-GAAP measures to evaluate its business, the substance behind

Boston Scientific management's decision to use these non-GAAP measures,

the material limitations associated with the use of these non-GAAP

measures, the manner in which Boston Scientific management compensates for

those limitations, and the substantive reasons why Boston Scientific

management believes that these non-GAAP measures provide useful

information to investors is included in the exhibit labeled "Use of Non-

GAAP Financial Measures.

BOSTON SCIENTIFIC CORPORATION

ESTIMATED NON-GAAP NET INCOME PER SHARE RECONCILIATIONS

(Unaudited)

Q1 2008 Estimate Q1 2008 Estimate

(Low) (High)

GAAP results $0.13 $0.18

Estimated acquisition and

divestiture-related net gains (0.07)
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related biology technology :

1. Boston Scientific to Participate in Merrill Lynch Conference
2. CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium
3. Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses
4. Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program
5. Boston Scientific Announces Results for Third Quarter Ended September 30, 2007
6. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
7. The 58th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Nov. 2-6
8. Boston Scientific Announces European Approval of Next-Generation Implantable Defibrillator
9. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
10. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
11. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2014)... 2014 The “Human Insulin Market- ... Acting, Premixed), Modern Human Insulin (Rapid Acting, Long ... Novomix, Tresiba, Others) - Forecast to 2018” provides ... challenges, opportunities, current market trends, and strategies impacting ... estimates and forecasts of the revenue and share ...
(Date:10/18/2014)... 2014 The Asia-Pacific hardware encryption display ... Asia-Pacific with analysis and forecast of revenue. This market ... to reach $51,362.6 million by 2018, at a CAGR ... the TOC of the Asia-Pacific hardware encryption market report, ... This also provides a glimpse of the segmentation of ...
(Date:10/18/2014)... to a new market research report “Hydraulic Fracturing Market ... Forecasts up till 2017”, hydraulic fracturing market will grow ... expected to increase from $40 billion in 2012 to ... same period. North America is expected to lead the ... horse power supplied by the year 2011. , Make ...
(Date:10/17/2014)... in Alice,s journey through the looking-glass to Wonderland, mirrors ... and unexpected ways, including a new class of mirror ... today in The Optical Society,s (OSA) new high-impact journal ... the first time, a new type of mirror that ... infrared light by using an unusual magnetic property of ...
Breaking Biology Technology:Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 2Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 3Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 4Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 5The Asia-Pacific hardware encryption display market is expected to reach $51,362.6 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific hardware encryption display market is expected to reach $51,362.6 million by 2018 - New Report by MicroMarket Monitor 3Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 2Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 3Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 4Magnetic mirrors enable new technologies by reflecting light in uncanny ways 2Magnetic mirrors enable new technologies by reflecting light in uncanny ways 3Magnetic mirrors enable new technologies by reflecting light in uncanny ways 4
... (Nasdaq: TELK ) announced results of studies on two ... annual meeting of the American Association for Cancer Research (AACR) in ... website, www.telik.com . In vivo ... VEGFR Inhibitors; Abstract # 1764 , Aurora kinases are Ser/Thr ...
... 28 Beckman Coulter, Inc. (NYSE: ... Directors declared a quarterly dividend payout of seventeen ... payable on May 22, 2009 to all stockholders ... payout represents the 80th consecutive, quarterly payout of ...
... COUNTY, Calif., April 28 Beckman Coulter, Inc. (NYSE: ... manufacturer and marketer of products that simplify, automate and ... March 31, 2009 results. For the first quarter, ... in constant currency terms. On a constant currency ...
Cached Biology Technology:Telik Reports Preclinical Results at AACR Annual Meeting 2Telik Reports Preclinical Results at AACR Annual Meeting 3Beckman Coulter Announces First Quarter 2009 Results 2Beckman Coulter Announces First Quarter 2009 Results 3Beckman Coulter Announces First Quarter 2009 Results 4Beckman Coulter Announces First Quarter 2009 Results 5Beckman Coulter Announces First Quarter 2009 Results 6Beckman Coulter Announces First Quarter 2009 Results 7Beckman Coulter Announces First Quarter 2009 Results 8Beckman Coulter Announces First Quarter 2009 Results 9Beckman Coulter Announces First Quarter 2009 Results 10Beckman Coulter Announces First Quarter 2009 Results 11Beckman Coulter Announces First Quarter 2009 Results 12Beckman Coulter Announces First Quarter 2009 Results 13Beckman Coulter Announces First Quarter 2009 Results 14Beckman Coulter Announces First Quarter 2009 Results 15Beckman Coulter Announces First Quarter 2009 Results 16Beckman Coulter Announces First Quarter 2009 Results 17Beckman Coulter Announces First Quarter 2009 Results 18Beckman Coulter Announces First Quarter 2009 Results 19Beckman Coulter Announces First Quarter 2009 Results 20Beckman Coulter Announces First Quarter 2009 Results 21Beckman Coulter Announces First Quarter 2009 Results 22Beckman Coulter Announces First Quarter 2009 Results 23Beckman Coulter Announces First Quarter 2009 Results 24Beckman Coulter Announces First Quarter 2009 Results 25Beckman Coulter Announces First Quarter 2009 Results 26Beckman Coulter Announces First Quarter 2009 Results 27Beckman Coulter Announces First Quarter 2009 Results 28Beckman Coulter Announces First Quarter 2009 Results 29
(Date:10/15/2014)... 15, 2014 NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market releases photos and video of ... on Monday October 13 th . Gino ... and angel investor Mr. Chad A. Verdi rang ... NXT-ID thanked his investors and employees "for their work and dedication ...
(Date:10/15/2014)... , Oct. 15, 2014   Neurotechnology ... today announced the availability of the VeriLook ... Surveillance 3.0 provides real-time biometric face identification using ... digital surveillance cameras. The new version not only ... differentiates people from objects while they are moving ...
(Date:10/14/2014)... Cancer Research shows SIRT6—a protein known to inhibit ... development of skin cancers by turning on an enzyme ... cells. , Previously considered protective, SIRT6 is part of ... regulate genomic stability and prevent some of the genetic ... which can lead to cancer. This study, in the ...
Breaking Biology News(10 mins):Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 2VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 3Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
... 9, 2009 -- Researchers at the Burnham Institute ... algorithms used in digital communications can help scientists ... Giovanni Paternostro, M.D., Ph.D., was published in the ... Biology . Using the stack sequential algorithm, ...
... unveil a novel "two-stage, approach for developing new energy ... emissions and create a cleaner economy during a policy ... York Ave. N.W. in Washington, D.C. , ... Mellon, the University of Minnesota, The Vermont Law School ...
... As children transition from preschool-age to school-age, they ... not meet current recommendations and may contribute to childhood ... issue of the Journal of Nutrition Education and ... pre-school children (2 to 5 years) had relatively good ...
Cached Biology News:Digital communication technology helps clear path to personalized therapies 2Carnegie Mellon to unveil new sequestration plan 2Eating habits and exercise behaviors in children can deteriorate early 2
Rac1/2/3 (L129) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
TUP1 Market Segment: Molecular Biology...
... UbcH7 interacts with the HECT ... RING domain. Evidence suggests that ... both the degradation of non-""N-end ... certain N-a -acetylated proteins as ...
COMING SOON: Anti-Mouse C5a Receptor (CD88), Clone 10/92 Monoclonal Antibody...
Biology Products: